1. Home
  2. CNTX vs IZEA Comparison

CNTX vs IZEA Comparison

Compare CNTX & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • IZEA
  • Stock Information
  • Founded
  • CNTX 2015
  • IZEA 2006
  • Country
  • CNTX United States
  • IZEA United States
  • Employees
  • CNTX N/A
  • IZEA N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • CNTX Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • CNTX Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • CNTX 75.6M
  • IZEA 60.8M
  • IPO Year
  • CNTX 2021
  • IZEA N/A
  • Fundamental
  • Price
  • CNTX $0.85
  • IZEA $3.57
  • Analyst Decision
  • CNTX Strong Buy
  • IZEA
  • Analyst Count
  • CNTX 5
  • IZEA 0
  • Target Price
  • CNTX $5.25
  • IZEA N/A
  • AVG Volume (30 Days)
  • CNTX 121.2K
  • IZEA 97.8K
  • Earning Date
  • CNTX 11-05-2025
  • IZEA 11-13-2025
  • Dividend Yield
  • CNTX N/A
  • IZEA N/A
  • EPS Growth
  • CNTX N/A
  • IZEA N/A
  • EPS
  • CNTX N/A
  • IZEA N/A
  • Revenue
  • CNTX N/A
  • IZEA $36,935,906.00
  • Revenue This Year
  • CNTX N/A
  • IZEA $11.15
  • Revenue Next Year
  • CNTX N/A
  • IZEA $17.64
  • P/E Ratio
  • CNTX N/A
  • IZEA N/A
  • Revenue Growth
  • CNTX N/A
  • IZEA 12.49
  • 52 Week Low
  • CNTX $0.49
  • IZEA $1.68
  • 52 Week High
  • CNTX $2.59
  • IZEA $4.39
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 55.84
  • IZEA 50.37
  • Support Level
  • CNTX $0.81
  • IZEA N/A
  • Resistance Level
  • CNTX $0.87
  • IZEA $3.90
  • Average True Range (ATR)
  • CNTX 0.05
  • IZEA 0.29
  • MACD
  • CNTX -0.01
  • IZEA -0.18
  • Stochastic Oscillator
  • CNTX 39.79
  • IZEA 84.20

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: